Featured Research

from universities, journals, and other organizations

Newly Identified Protein Linked To Cancer Cell Survival

Date:
March 18, 2002
Source:
Vanderbilt University Medical Center
Summary:
Investigators have identified a new secreted protein and its receptors that appear to give a cancer cell the ability to fuel its own growth and present a potential target for anti-cancer drugs.

A team of Vanderbilt-Ingram Cancer Center investigators have identified a new secreted protein and its receptors that appear to give a cancer cell the ability to fuel its own growth and present a potential target for anti-cancer drugs.

Related Articles


Secreted proteins are released from one cell to transmit a signal to another cell instructing a particular behavior such as cell growth, migration or survival. These proteins cannot act alone; they must act through a receptor or receptors on the receiving cell, so discovery of the receptor is also important.

Initially called MOB-5, this new protein has been renamed Interleukin 24 (IL-24), with the approval of the Human Genome Nomenclature Committee, because the investigators’ work demonstrates relationship to the family of proteins known as interleukins. These proteins are typically secreted by immune system cells in response to a triggering event, such as injury or infection. However, the Vanderbilt-Ingram team has found IL-24 and two receptors expressed in colon cancer cells, making it the first interleukin to be found along with its receptors in tumor cells.

"There is an old saying that cancer is like a wound that never heals," said Peng Liang, Ph.D., associate professor of Cancer Biology, whose laboratory did the work reported this month in the Journal of Biological Chemistry. "This gives credence to that old saying."

Using a process called differential display to compare gene expression between cancer and normal cells, the team found this gene to be expressed only in tumor cells and particularly those in which the oncogene (cancer-causing gene) RAS is activated. RAS is mutated frequently in colon and pancreas cancers, among others, and it appears from this group’s work that RAS activation leads to unregulated expression of IL-24 and its receptors.

"At the time, we didn’t know it was an interleukin, just that it was a secreted protein," Liang said. "Finding the difference between tumor and normal cells is really only the beginning of the story."

Once the team cloned the gene, however, its similarity to IL-10 and two other related interleukins, IL20 and IL22, was apparent, Liang said. Further research to test binding between IL-24 and the known receptors in the IL-10 family found that IL-24 binds to two different two-part (heterodimeric) receptors, and that it shares a subunit of these receptors with IL-20 and IL-22.

"If they share both sequence homology and receptor subunits, it provides strong molecular evidence that these interleukins are related," Liang said. "As a result, MOB-5 was properly renamed as a new interleukin."

The scientists also demonstrated that IL-24 can promote cell growth or prevent cell death. This was done using hemopoietic mouse cells that must have interleukin-3 (IL-3) to grow and survive. When the cells were made to express IL-24 receptors, in the absence of both Il-3 and IL-24, the cells died. In the absence of IL-3 but the presence of IL-24, the cells continued to live and grow.

Finding that IL-24 can support cell survival, and finding both IL-24 and its receptors in tumor cells, has an important implication, Liang said. This creates what is called an autocinre loop, through which a cell secretes a protein that then binds to a receptor on itself, sending its own signal to its nucleus. "The cell could then fuel its own growth and survival without the checks and balances by the neighboring cells," Liang said.

The next step will be to try to develop molecules to interrupt this autocrine loop, either by intercepting the IL-24 protein outside the cell after it is secreted, or by blocking the receptors so that the protein cannot bind and therefore transmit its signal back into the cell.

The team’s most recent work was published in the March 1 issue of the Journal of Biological Chemistry. It was supported in part by the National Institutes of Health. Vanderbilt co-authors include graduate student Mai Wang, and postdoctoral fellows Zhongjia Tan and Rong Zhang of the Department of Cancer Biology.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "Newly Identified Protein Linked To Cancer Cell Survival." ScienceDaily. ScienceDaily, 18 March 2002. <www.sciencedaily.com/releases/2002/03/020313080257.htm>.
Vanderbilt University Medical Center. (2002, March 18). Newly Identified Protein Linked To Cancer Cell Survival. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2002/03/020313080257.htm
Vanderbilt University Medical Center. "Newly Identified Protein Linked To Cancer Cell Survival." ScienceDaily. www.sciencedaily.com/releases/2002/03/020313080257.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins